High Transepidermal Water Loss in Diabetic Foot Ulcer Tied to Recurrence
By Elana Gotkine HealthDay Reporter
TUESDAY, June 3, 2025 -- Compromised restoration of the skin barrier function of closed diabetic foot ulcers (DFUs), as measured by high transepidermal water loss (TEWL), is associated with increased odds of recurrence, according to a study published online May 30 in Diabetes Care.
Chandan K. Sen, Ph.D., from the McGowan Institute for Regenerative Medicine at the University of Pittsburgh, and colleagues conducted a multicenter, noninterventional study measuring TEWL in 418 adults with diabetes and a recently healed DFU. Within two weeks of wound closure, TEWL was measured at the center of the closed wound and at an anatomically similar reference area on the contralateral foot; measurements were repeated two weeks later at a wound closure confirmation visit (visits 1 and 2, respectively). To examine wound recurrence, participants were observed for up to 16 weeks.
The researchers found that DFU recurrence occurred in 21.5 percent of participants by week 16. At visit 1, mean TEWL at the center of the healed DFU was higher for those with recurrence versus those without. Overall, 35 and 17 percent of those with high TEWL and low TEWL, respectively, reported wound recurrence. For participants with high TEWL, the odds ratio for recurrence was 2.66. There was high concordance for self-reported wound recurrence with clinician assessment of wound recurrence.
“This study is an important initial step to give clinicians treating diabetic foot ulcers a reliable diagnostic aid for the first time to assess an individual’s risk of ulcer recurrence,” study author Teresa Jones, M.D., from the National Institute of Diabetes and Digestive and Kidney Diseases in Bethesda, Maryland, said in a statement. “Foot ulcers are such a confounding issue with diabetes and being able to determine which wounds are at highest risk for recurrence could save many lives and limbs.”
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-06-04 06:00
Read more

- Odds of Cardiovascular Events Up for RSV Hospitalization Versus COVID-19 Hospitalization
- Hormel Recalls Over 256,000 Pounds of Canned Beef Stew
- Pheast Therapeutics Receives FDA Fast Track Designation for PHST001 for the Treatment of Ovarian Cancer
- ASCO: Durvalumab Plus FLOT Beneficial for Resectable Gastric, GE Junction Cancer
- Axsome Therapeutics Provides Update on the New Drug Application (NDA) for AXS-14 for the Management of Fibromyalgia
- High-Volume Exercise Tied to Increased Coronary Artery Calcification Score
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions